By Daniel Oluwatobiloba Popoola
Nigeria’s First Lady, Senator Oluremi Tinubu, has renewed the country’s commitment to ending malaria, urging stronger partnerships, increased domestic financing and innovative solutions to confront one of Nigeria’s most persistent public health threats.
In her message marking World Malaria Day 2026 on Friday, 25 April Tinubu said the global theme, “United Against Malaria,” highlighted the urgent need for sustained collaboration to tackle growing challenges such as drug resistance and unequal access to healthcare.
She added that the annual observance offered another opportunity to reinforce efforts aimed at protecting every individual, especially vulnerable communities.
According to the First Lady, defeating malaria will require coordinated action among government institutions, healthcare providers, development partners and local communities.
She noted that increased investment in home-grown health interventions remains critical to widening prevention and treatment services nationwide.
“The 2026 theme, ‘United Against Malaria,’ highlights the urgent need for sustained collaboration, increased investment through domestic financing, and innovative solutions to overcome challenges such as drug resistance and unequal access to healthcare,” she said.
She further called for stronger preventive measures and continued support for life-saving interventions designed to reduce the burden of the disease.
“Let us strengthen prevention efforts, support life-saving interventions, and ensure that every community, especially the most vulnerable, has access to the materials needed to prevent and treat malaria,” Tinubu said.
The First Lady expressed confidence that collective resolve could significantly cut infections and malaria-related deaths.
“When we stand united, we can achieve a malaria-free world,” she added.
World Malaria Day is observed annually on April 25 to raise awareness, mobilise resources and accelerate efforts to eliminate malaria.
Nigeria remains among the countries hardest hit by the disease, making sustained advocacy and investment vital to improved national health outcomes.
